BioSpace News Archive

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting the epigenetic causes of cancers, today announced its participation at two upcoming investor conferences.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced three new patents for inventions related to cryopreservation, thawing and cold chain transport technologies

Pharmaceutical and biopharmaceutical manufacturers can now verify the identity of ionic salts in the warehouse in a matter of seconds with a new portable X-ray fluorescence (XRF) analyzer.

Fresenius Medical Care North America (FMCNA), the nation’s leading provider of kidney care products and services, released the following statement in response to the signing of AB 290 in California

Promotions of Elisa Romeo and Greg Nagy as well as the addition of Kamraan Shariff.

Univfy®, an AI platform company whose mission is to improve fertility patients’ experience and access to in vitro fertilization (IVF), announced today a collaboration with BBVA USA, the US subsidiary of global financial institution BBVA, to offer a finance program with rates starting at 0% APR (up to 18.99%).

Children with asthma who are required to switch inhaler types to accommodate insurance formulary changes may experience a loss of lung function not seen in children whose inhaler type stayed the same, according to Scott Bickel, MD, from the University of Louisville School of Medicine, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.

Coupled with new research on brain cell types and connections, these data allow the scientific community to explore questions about brain diseases and psychiatric disorders

Cook Medical is proud to announce that Dave Reed, vice president of Healthcare Solutions, received the Chuck Lauer Award at the Integrated Delivery Network (IDN) Summit on September 10.

Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, October 31, 2019 outlining its third quarter 2019 financial results.